SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Weyerhaeuser Company (WY) trades at a trailing P/E of 54.8, forward P/E of 86.9. Trailing earnings yield is 1.82%, forward earnings yield 1.15%. PEG 0.89 (Peter Lynch undervalued ≤1.0). Graham Number is $11.49.
Criteria proven by this page:
- VALUE (71/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.89); analyst target implies upside (+21.9%).
- PEG Ratio 0.89 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.82% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $30.20 (+21.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 48/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
71/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — WY
Valuation Multiples
P/E (TTM)54.8
Forward P/E86.9
PEG Ratio0.89
Forward PEG0.89
P/B Ratio1.88
P/S Ratio2.55
EV/EBITDA21.9
Per Share Data
EPS (TTM)$0.45
Forward EPS (Est.)$0.29
Book Value / Share$13.07
Revenue / Share$9.64
FCF / Share$0.76
Yields & Fair Value
Earnings Yield1.82%
Forward Earnings Yield1.15%
Dividend Yield3.41%
Graham Number$11.49
SharesGrow IV$24.13 (-2.6%)
Analyst Target$30.20 (+21.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
21.1 |
0.37 |
2.36 |
3.40 |
4.41% |
| 2017 |
45.6 |
-1.01 |
2.98 |
3.69 |
3.54% |
| 2018 |
22.1 |
0.77 |
1.82 |
2.21 |
6.03% |
| 2019 |
-296.4 |
2.69 |
2.75 |
3.44 |
4.50% |
| 2020 |
31.4 |
-0.03 |
2.87 |
3.33 |
1.52% |
| 2021 |
11.8 |
0.05 |
2.87 |
3.03 |
2.86% |
| 2022 |
12.2 |
-0.45 |
2.14 |
2.26 |
7.03% |
| 2023 |
30.3 |
-0.56 |
2.49 |
3.32 |
4.78% |
| 2024 |
51.8 |
-0.98 |
2.11 |
2.88 |
3.34% |
| 2025 |
52.7 |
-3.16 |
1.81 |
2.47 |
3.55% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.39 |
$6.37B |
$1.03B |
16.1% |
| 2017 |
$0.77 |
$7.2B |
$582M |
8.1% |
| 2018 |
$0.99 |
$7.48B |
$748M |
10% |
| 2019 |
$-0.10 |
$6.55B |
$-76M |
-1.2% |
| 2020 |
$1.07 |
$7.53B |
$797M |
10.6% |
| 2021 |
$3.47 |
$10.2B |
$2.61B |
25.6% |
| 2022 |
$2.53 |
$10.18B |
$1.88B |
18.5% |
| 2023 |
$1.15 |
$7.67B |
$839M |
10.9% |
| 2024 |
$0.54 |
$7.12B |
$396M |
5.6% |
| 2025 |
$0.45 |
$6.91B |
$324M |
4.7% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.28 |
$0.13 – $0.54 |
$7.12B |
$7.07B – $7.25B |
8 |
| 2027 |
$0.71 |
$0.44 – $0.99 |
$7.75B |
$7.42B – $8.1B |
7 |
| 2028 |
$1.12 |
$1.07 – $1.16 |
$8.04B |
$7.77B – $8.28B |
1 |
